Bioter S.A. (ATH:BIOT)

Bioter Statistics

Total Valuation

Bioter has a market cap or net worth of EUR 3.45 million. The enterprise value is 192.75 million.

Market Cap	3.45M
Enterprise Value	192.75M

Important Dates

The next estimated earnings date is Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	n/a

Share Statistics

Bioter has 16.73 million shares outstanding.

Current Share Class	16.73M
Shares Outstanding	16.73M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.08%
Owned by Insiders (%)	43.21%
Owned by Institutions (%)	n/a
Float	6.58M

Valuation Ratios

The trailing PE ratio is 0.09.

PE Ratio	0.09
Forward PE	n/a
PS Ratio	2.73
PB Ratio	-0.04
P/TBV Ratio	n/a
P/FCF Ratio	0.07
P/OCF Ratio	0.07
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.52, with an EV/FCF ratio of 3.95.

EV / Earnings	5.04
EV / Sales	152.73
EV / EBITDA	4.52
EV / EBIT	4.53
EV / FCF	3.95

Financial Position

The company has a current ratio of 0.15

Current Ratio	0.15
Quick Ratio	0.15
Debt / Equity	n/a
Debt / EBITDA	3.15
Debt / FCF	2.74
Interest Coverage	6.85

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	36.56%
Return on Invested Capital (ROIC)	47.91%
Return on Capital Employed (ROCE)	-52.64%
Revenue Per Employee	315,500
Profits Per Employee	9.56M
Employee Count	4
Asset Turnover	0.02
Inventory Turnover	5.16

Taxes

Income Tax	-1.24M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -11.21% in the last 52 weeks. The beta is 1.01, so Bioter's price volatility has been similar to the market average.

Beta (5Y)	1.01
52-Week Price Change	-11.21%
50-Day Moving Average	0.20
200-Day Moving Average	0.25
Relative Strength Index (RSI)	49.59
Average Volume (20 Days)	338

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bioter had revenue of EUR 1.26 million and earned 38.24 million in profits. Earnings per share was 2.29.

Revenue	1.26M
Gross Profit	955,000
Operating Income	42.42M
Pretax Income	37.06M
Net Income	38.24M
EBITDA	42.49M
EBIT	42.42M
Earnings Per Share (EPS)	2.29

Balance Sheet

The company has 499,000 in cash and 133.77 million in debt, giving a net cash position of -133.27 million or -7.96 per share.

Cash & Cash Equivalents	499,000
Total Debt	133.77M
Net Cash	-133.27M
Net Cash Per Share	-7.96
Equity (Book Value)	-85.37M
Book Value Per Share	-5.08
Working Capital	-122.07M

Cash Flow

In the last 12 months, operating cash flow was 48.84 million and capital expenditures -58,000, giving a free cash flow of 48.78 million.

Operating Cash Flow	48.84M
Capital Expenditures	-58,000
Free Cash Flow	48.78M
FCF Per Share	2.92

Margins

Gross margin is 75.67%, with operating and profit margins of 3,361.25% and 3,030.43%.

Gross Margin	75.67%
Operating Margin	3,361.25%
Pretax Margin	2,936.77%
Profit Margin	3,030.43%
EBITDA Margin	3,367.12%
EBIT Margin	3,361.25%
FCF Margin	3,865.45%

Dividends & Yields

Bioter does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	1,109.37%
FCF Yield	1,415.05%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 9, 2010. It was a reverse split with a ratio of 0.25.

Last Split Date	Aug 9, 2010
Split Type	Reverse
Split Ratio	0.25

Scores

Bioter has an Altman Z-Score of -4.14 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.14
Piotroski F-Score	6